CFG
89
4
LNC
65
3
BRK.B
47
-2
FLR
46
3
FE
53
-2
MCK
62
-5
PAYX
45
7
F
59
3
MMC
60
2
ETN
63
3
DTE
43
3
SLG
45
-3
GIS
57
2
EL
62
3
GM
79
4
XOM
64
8
ES
40
-2
SHW
59
3
YUM
52
2
PNR
63
3
CFG
89
4
LNC
65
3
BRK.B
47
-2
FLR
46
3
FE
53
-2
MCK
62
-5
PAYX
45
7
F
59
3
MMC
60
2
ETN
63
3
DTE
43
3
SLG
45
-3
GIS
57
2
EL
62
3
GM
79
4
XOM
64
8
ES
40
-2
SHW
59
3
YUM
52
2
PNR
63
3
Financhill
Back

Universe Pharmaceuticals, Inc. 10K Form

Sell
18

UPC
Universe Pharmaceuticals, Inc.

Last Price:
$4.02
Seasonality Move:
-34.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UPC News And Ratings

See the #1 stock for the next 7 days that we like better than UPC

UPC Financial Statistics

Sales & Book Value

Annual Sales: $23M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $110.01
Price / Book: 0.04

Profitability

EPS (TTM): -76.35000
Net Income (TTM): $-18.5M
Gross Margin: $5.8M
Return on Equity: -49.07%
Return on Assets: -32.15%

Universe Pharmaceuticals, Inc. Earnings Forecast

Key Universe Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 7 years for UPC is 25.29%.
  • The Selling, General & Administrative Expenses for UPC have been equal to 48.04% of Gross Profit Margin.
  • The Research & Development expenses have been 13.00% of Revenue.
  • The Net Earning history of UPC is -37.90% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Universe Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: UPC
Website: universe-pharmacy.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 1.63
Quick Ratio: 1.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

UPC Technical Analysis vs Fundamental Analysis

Sell
18
Universe Pharmaceuticals, Inc. (UPC) is a Sell

Is Universe Pharmaceuticals, Inc. a Buy or a Sell?